We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Booz Allen Hamilton
BAH
$8.85B
| $18.9M | 0.04% |
581,770
-560,615
| -49% | -$20.2M |
|
|
RP
252
DELISTED
RealPage, Inc.
RP
| $18.8M | 0.04% |
521,582
-11,459
| -2% | -$409K |
|
253
Dollar General
DG
$28.1B
| $18.7M | 0.04% |
259,865
-250,264
| -49% | -$18M |
|
254
Camping World
CWH
$676M
| $18.7M | 0.04% |
605,617
+173,486
| +40% | +$5.13M |
|
255
LiveRamp
RAMP
$2.3B
| $18.7M | 0.04% |
718,891
+103,439
| +17% | +$2.81M |
|
|
PACW
256
DELISTED
PacWest Bancorp
PACW
| $18.6M | 0.04% |
397,986
-40,558
| -9% | -$1.98M |
|
|
INVX
257
Innovex International
INVX
$2.21B
| $18.4M | 0.04% |
377,291
+335
| +0.1% | +$17.3K |
|
|
GHDX
258
DELISTED
Genomic Health, Inc.
GHDX
| $18.4M | 0.04% |
565,324
-19,191
| -3% | -$608K |
|
|
BMTC
259
DELISTED
Bryn Mawr Bank Corp
BMTC
| $18.3M | 0.04% |
430,642
-32,891
| -7% | -$1.36M |
|
260
Teleflex
TFX
$6.2B
| $18.3M | 0.04% |
87,901
-16,146
| -16% | -$3.24M |
|
261
Astec Industries
ASTE
$1.2B
| $18.2M | 0.04% |
328,640
-11,127
| -3% | -$655K |
|
262
NorthWestern Energy
NWE
$4.3B
| $18.2M | 0.04% |
298,531
-24,462
| -8% | -$1.49M |
|
263
Korn Ferry
KFY
$4.23B
| $18.2M | 0.04% |
526,569
-4,714
| -0.9% | -$153K |
|
264
AtriCure
ATRC
$1.98B
| $18.2M | 0.04% |
749,408
-21,957
| -3% | -$467K |
|
265
Prothena Corp
PRTA
$444M
| $18.1M | 0.04% |
334,914
+7,139
| +2% | +$380K |
|
|
BMCH
266
DELISTED
BMC Stock Holdings, Inc
BMCH
| $18M | 0.04% |
823,205
+657,055
| +395% | +$14.3M |
|
|
AXDX
267
DELISTED
Accelerate Diagnostics
AXDX
| $18M | 0.04% |
65,666
-2,237
| -3% | -$606K |
|
268
Neogen
NEOG
$2.58B
| $17.9M | 0.04% |
690,965
-23,403
| -3% | -$560K |
|
269
Altria Group
MO
$114B
| $17.8M | 0.04% |
239,443
+210,519
| +728% | +$15.4M |
|
270
Columbia Sportswear
COLM
$2.95B
| $17.7M | 0.04% |
305,441
+925
| +0.3% | +$52.3K |
|
271
Constellation Brands
STZ
$22.4B
| $17.7M | 0.04% |
91,113
-45,944
| -34% | -$8.18M |
|
|
CADE
272
DELISTED
Cadence Bank
CADE
| $17.6M | 0.04% |
578,338
-5,095
| -0.9% | -$153K |
|
|
MIME
273
DELISTED
Mimecast Limited
MIME
| $17.4M | 0.04% |
649,030
+141,954
| +28% | +$3.56M |
|
|
NXTM
274
DELISTED
NxStage Medical Inc.
NXTM
| $17.3M | 0.04% |
689,146
-19,800
| -3% | -$490K |
|
275
Home Depot
HD
$347B
| $17.2M | 0.04% |
112,418
-48,561
| -30% | -$7.45M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.